Trademarkia Logo

Australia

AU$
Trademark Search
QVEQLI

View On IPO.GOV.AU

QVEQLI
Protected: Registered/protected

Last updated on 7 Mar 2024

Owner Info

Ascendis Pharma Endocrinology Division A/S

c/o Ascendis Pharma A/S,

Tuborg Boulevard 5, DENMARK

Serial Number

2126810 filed on 18 Jun 2020

Correspondent

Abion IPR ApS

Vejlsøvej 51,

DK-8600 Silkeborg,

DENMARK

QVEQLI

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutica Read More

Class [009]
Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health ins Read More

Class [010]
Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for Read More

Mark Details

Serial Number

2126810

Registered On

18 Jun 2020

Renewal On

18 Jun 2030

Mark Type

WORD

Priority Claim (Convention Details)

Date

30 Dec 2019

Mark Type

DK

Legal History

Show more

Status DateAction Taken
7th Mar 2024Amendment to International Registration Contact Requested
26th Jan 2021International Registration in Australia Protected correspondence sent
25th Jan 2021IP Right Registration Published
25th Jan 2021Status change to Registered/Protected
18th Nov 2020Application Accepted correspondence sent
17th Nov 2020IP Right has been Examined
17th Nov 2020IP Right Acceptance Published
17th Nov 2020Status change to Accepted
12th Oct 2020Examination expedited
12th Oct 2020Awaiting examination